loadpatents
name:-0.15326404571533
name:-0.10770583152771
name:-0.016240119934082
Thalladi; Venkat R. Patent Filings

Thalladi; Venkat R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thalladi; Venkat R..The latest application filed is for "crystalline form of a dihydrochloride salt of a jak inhibitor compound".

Company Profile
23.43.54
  • Thalladi; Venkat R. - Foster City CA
  • Thalladi; Venkat R. - Santa Clara CA
  • Thalladi; Venkat R. - Worcester MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystalline Form Of A Dihydrochloride Salt Of A Jak Inhibitor Compound
App 20220306626 - Nzerem; Jerry ;   et al.
2022-09-29
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease
App 20220306624 - Fatheree; Paul R. ;   et al.
2022-09-29
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
Grant 11,452,723 - Li , et al. September 27, 2
2022-09-27
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof
App 20220242836 - Hughes; Adam D. ;   et al.
2022-08-04
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors
App 20220119369 - McKinnell; Robert Murray ;   et al.
2022-04-21
Formulation Of A Pan-jak Inhibitor
App 20220112220 - Nitert; Bernardus Joseph ;   et al.
2022-04-14
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
Grant 11,230,536 - Hughes , et al. January 25, 2
2022-01-25
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20210401808 - Fleury; Melissa ;   et al.
2021-12-30
Methods of treatment using a JAK inhibitor compound
Grant 11,160,800 - Thalladi , et al. November 2, 2
2021-11-02
Fused imidazo-piperidine JAK inhibitor compound
Grant 11,160,810 - McKinnell , et al. November 2, 2
2021-11-02
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20210179637 - Hudson; Ryan ;   et al.
2021-06-17
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 11,033,533 - Fleury , et al. June 15, 2
2021-06-15
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent
App 20210161884 - Li; Shaoling ;   et al.
2021-06-03
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
Grant 10,968,205 - McKinnell , et al. April 6, 2
2021-04-06
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
Grant 10,946,009 - Li , et al. March 16, 2
2021-03-16
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
Grant 10,947,254 - Hudson , et al. March 16, 2
2021-03-16
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof
App 20210061776 - Hughes; Adam D. ;   et al.
2021-03-04
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 10,913,740 - Fatheree , et al. February 9, 2
2021-02-09
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20200281900 - Fleury; Melissa ;   et al.
2020-09-10
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
Grant 10,752,599 - Hughes , et al. A
2020-08-25
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors
App 20200216423 - MCKINNELL; ROBERT MURRAY ;   et al.
2020-07-09
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(- 3-hydroxyisoxazole-5-carboxamido)-2-methy
App 20200157061 - Hughes; Adam D. ;   et al.
2020-05-21
Methods Of Treatment Using A Jak Inhibitor Compound
App 20200121669 - THALLADI; VENKAT R. ;   et al.
2020-04-23
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20200087303 - Fatheree; Paul R. ;   et al.
2020-03-19
Fused Imidazo-piperidine Jak Inhibitor Compound
App 20200046719 - MCKINNELL; ROBERT MURRAY ;   et al.
2020-02-13
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20200040010 - Hudson; Ryan ;   et al.
2020-02-06
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 10,548,879 - Fleury , et al. Fe
2020-02-04
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
Grant 10,538,513 - McKinnell , et al. Ja
2020-01-21
Fused imidazo-piperidine JAK inhibitor compound
Grant 10,493,077 - Fatheree , et al. De
2019-12-03
Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water
Grant 10,494,382 - Huang , et al. De
2019-12-03
Crystalline(2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-bipheny]-4-yl)-2-(ethoxyme- thyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
Grant 10,472,335 - Hughes , et al. Nov
2019-11-12
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent
App 20190321350 - Li; Shaoling ;   et al.
2019-10-24
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors
App 20190315724 - MCKINNELL; ROBERT MURRAY ;   et al.
2019-10-17
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20190269659 - Fleury; Melissa ;   et al.
2019-09-05
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
Grant 10,392,368 - Fenster , et al. A
2019-08-27
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
Grant 10,369,142 - Li , et al.
2019-08-06
Crystalline forms of a JAK inhibitor compound
Grant 10,251,874 - Dabros , et al.
2019-04-09
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors
App 20190040043 - FENSTER; ERIK ;   et al.
2019-02-07
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 10,183,942 - Benjamin , et al. Ja
2019-01-22
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 10,172,834 - Fleury , et al. J
2019-01-08
Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-bipheny]-4-yl)-2-(ethoxyme- Thyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof
App 20190002416 - Hughes; Adam D. ;   et al.
2019-01-03
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20180354974 - Huang; Xiaojun ;   et al.
2018-12-13
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20180319796 - Benjamin; Noah ;   et al.
2018-11-08
Crystalline Forms Of A Jak Inhibitor Compound
App 20180311223 - DABROS; MARTA ;   et al.
2018-11-01
Fused Imidazo-piperidine Jak Inhibitor Compound
App 20180311255 - FATHEREE; PAUL R. ;   et al.
2018-11-01
Methods Of Treatment Using A Jak Inhibitor Compound
App 20180311226 - THALLADI; Venkat R. ;   et al.
2018-11-01
Crystalline(2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxym- ethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
Grant 10,100,021 - Hughes , et al. October 16, 2
2018-10-16
Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-- yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
Grant 10,072,026 - Huang , et al. September 11, 2
2018-09-11
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20180228774 - Fleury; Melissa ;   et al.
2018-08-16
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent
App 20180050028 - Li; Shaoling ;   et al.
2018-02-22
(2R,4R)-5-(5'-Chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 9,872,855 - Fleury , et al. January 23, 2
2018-01-23
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid
Grant 9,868,698 - Hughes , et al. January 16, 2
2018-01-16
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid
App 20170355665 - Hughes; Adam D. ;   et al.
2017-12-14
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20170305934 - Huang; Xiaojun ;   et al.
2017-10-26
Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-bipheny]-4-yl)-2-(ethoxyme- Thyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid And Uses Thereof
App 20170275259 - Hughes; Adam D. ;   et al.
2017-09-28
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20170196841 - Fleury; Melissa ;   et al.
2017-07-13
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xmethyl-2-methylpentanoic acid
Grant 9,670,143 - Hughes , et al. June 6, 2
2017-06-06
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20170121327 - Fatheree; Paul R. ;   et al.
2017-05-04
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid
App 20170088508 - Hughes; Adam D. ;   et al.
2017-03-30
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 9,533,962 - Fleury , et al. January 3, 2
2017-01-03
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20160347772 - Hudson; Ryan ;   et al.
2016-12-01
Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent
App 20160287573 - Li; Shaoling ;   et al.
2016-10-06
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid
Grant 9,433,598 - Hughes , et al. September 6, 2
2016-09-06
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20160244416 - Fleury; Melissa ;   et al.
2016-08-25
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid
App 20160228395 - Hughes; Adam D. ;   et al.
2016-08-11
Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl- )hydrazino]-2-hydroxyproprionic acid isopropyl ester
Grant 9,271,965 - Thalladi , et al. March 1, 2
2016-03-01
Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
Grant 9,249,105 - Fatheree , et al. February 2, 2
2016-02-02
Crystalline Forms Of A 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine Compound
App 20150141483 - Colson; Pierre-Jean ;   et al.
2015-05-21
Crystalline Forms Of An Alkoxyimidazol-1-ylmethyl Biphenyl Carboxylic Acid
App 20150133518 - Fatheree; Paul R. ;   et al.
2015-05-14
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
Grant 8,969,403 - Colson , et al. March 3, 2
2015-03-03
Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
Grant 8,883,135 - Thalladi , et al. November 11, 2
2014-11-11
Levodopa prodrug mesylate hydrate
Grant 8,722,733 - Karaborni , et al. May 13, 2
2014-05-13
Crystalline Forms Of A 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine Compound
App 20140121385 - Colson; Pierre-Jean ;   et al.
2014-05-01
Crystalline oxalate salts of a diamide compound
Grant 8,697,724 - Rapta , et al. April 15, 2
2014-04-15
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
Grant 8,658,691 - Colson , et al. February 25, 2
2014-02-25
Crystalline Form Of A Pyridyl-piperazinyl Hepatitis C Virus Inhibitor
App 20130295048 - Thalladi; Venkat R. ;   et al.
2013-11-07
Crystalline Forms Of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl- )hydrazino]-2-hydroxypropionic Acid Isopropyl Ester
App 20130259897 - Thalladi; Venkat R. ;   et al.
2013-10-03
Crystalline Forms Of A 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine Compound
App 20130085172 - COLSON; Pierre-Jean ;   et al.
2013-04-04
Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
Grant 8,362,060 - Fatheree , et al. January 29, 2
2013-01-29
Crystalline Forms Of An Alkoxyimidazol-1-ylmethyl Biphenyl Carboxylic Acid
App 20120115920 - FATHEREE; Paul R. ;   et al.
2012-05-10
Multi-transduction mechanism based microfluidic analyte sensors
Grant 7,935,309 - McGimpsey , et al. May 3, 2
2011-05-03
Selective Growth Of Stable Polymorphs
App 20110009623 - Cox; Jason R. ;   et al.
2011-01-13
Levodopa Prodrug Mesylate Hydrate
App 20100099761 - Karaborni; Sami ;   et al.
2010-04-22
Multi-transduction mechanism based microfluidic analyte sensors
App 20070042450 - McGimpsey; W. Grant ;   et al.
2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed